OMLIVULT

Class [005]
Pharmaceutical preparations for use in the treatment of cancer, autoimmune diseases, inflammation, inflammatory diseases and disorders, namely, Ankylosing spondylitis, scleroderma, asthma, celiac disease, gout, rheumatoid arthritis, prostatitis, colitis, diverticulitis, glomerulonephritis, hidradenitis, inflammatory bowel disease, Crohn's disease, ulcerative colitis, cystitis, myositis, lupus, mast cell activation syndrome, mastocytosis, otitis, sarcoidosis, transplant rejection, and vasculitis, neurologic diseases and disorders, namely, Amyotrophic lateral sclerosis (ALS), Alzheimer's disease, aneurysm, back pain, Bell's palsy, brain tumor, brain injury, Cerebral palsy, chronic fatigue syndrome, concussion, dementia, disk disease of neck and lower back, dizziness, epilepsy, Guillain-Barré syndrome, headaches and migraines, multiple sclerosis, muscular dystrophy, neuralgia, neuropathy, neuromuscular and related diseases, Parkinson's disease, severe depression, seizure disorders, obsessive-compulsive disorder, anxiety disorders, cognitive disorders, schizophrenia, scoliosis, spinal deformity and disorders, spine tumor, spinal cord injury, stroke, and vertigo, metabolic diseases and disorders, namely, diabetes, obesity, hypoglycaemia, cystic fibrosis, osteoarthritis, muscular dystrophy, and anemia, and cardiovascular diseases and disorders; pharmaceutical preparations for suppressing tumours